SURVEY OF PRESCRIPTION PATTERN OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE AND DIABETIC HYPERTENSIVE PATIENTS

  • Bipin B. Panda
  • Pratap K Sahu
  • Manas R Pati

Abstract

 

Objective: This study was conducted in order to establish the drug prescribing trend of anti-hypertensive agents in hypertensives and diabetic
hypertensives in General Medicine Department of Veer Surendra Sai Medical College and Hospital, Sambalpur, Odisha.
Methods: A prospective study of 2 months duration was conducted at the Veer Surendra Sai Medical College and Hospital, Sambalpur. The
prescriptions containing antihypertensives were collected from the patients attending the outpatient department of general medicine. Pregnant
women were excluded from the study.
Results: A total of 422 prescriptions were monitored, of which 285 were male and 137 were female. The age group of the patients varies from 35 to
75 years. Among 422 prescriptions, 118 prescriptions were of hypertensives and 304 prescriptions were diabetic hypertensives. Among hypertensives,
48% of patients were treated with anti-hypertensive drug combinations and 52% of patients were treated with single anti-hypertensive drug. 83%
patients are suffering from primary hypertension (HTN) and only 17% patients suffering from secondary HTN. For the treatment of HTN, both
monotherapy and combination therapy were followed. In monotherapy, amlodipine was most commonly prescribed followed by telmisartan. In
combination therapy, a two-drug combination consisting of calcium channel blockers (amlodipine) and beta blocker (atenolol) were given to the
majority of patients, followed by amlodipine and AT1 antagonist (telmisartan or olmesartan) combination. Among diabetic hypertensives, 31% of
patients were treated with single anti-hypertensive drug and 69% of patients were treated with anti-hypertensive drug combinations. In monotherapy,
beta-blocker (metoprolol) was most commonly prescribed. In combination therapy, a two-drug combination consisting of calcium channel blockers
(amlodipine) and beta blocker (atenolol or metoprolol) were given to the majority of patients, followed by a combination of calcium channel blockers
(amlodipine) and AT1 antagonist (telmisartan or olmesartan).
Conclusion: The present study represents the current prescribing trend for anti-hypertensive agents. According to JNC 7 guidelines, for Stage 1 HTN
(systolic blood pressure [SBP] 140-159 or diastolic blood pressure [DBP] 90-99 mmHg), thiazides-type diuretics should be prescribed. For Stage 2
HTN (SBP ≥160 or DBP ≥100 mmHg), two drug combinations (usually thiazide-type diuretics and angiotensin converting enzyme inhibitors) should
be prescribed. In our study, the prescription pattern does not follow the guideline.
Keywords: Hypertension, Prescription, Diabetes, Cardiovascular disease.

 

References

1. Arauz-Pacheco C, Parrott MA, Raskin P, American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2003;26 Suppl 1:S80-2.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J, et al. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365(9455):217-23.
3. McInnis NH, Fodor G, Lum-Kwong M, Leenen FH. Antihypertensive medication use and blood pressure control: A community-based cross-sectional survey (ON-BP). Am J Hypertens 2008;21(11):1210-5.
4. Yuen YH, Chang S, Chong CK, Lee SC, Critchley JA, Chan JC, et al. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther 1998;23:287-94.
5. Hansson L, Dahlöf B, Gudbrandsson T, Hellsing T, Kullman S, Kuylenstierna J, et al. Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy. J Cardiovasc Pharmacol 1988;12(1):94-101.
6. Mancia G, Grassi G. Antihypertensive treatment: Past, present and future. J Hypertens 1998;16:S1-7.
7. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004;43(5):993-1002.
8. Begum S, Akhter N. Cardioprotective effect of amlodipine in oxidative stress induced by experimental myocardial infarction in rats. Bangladesh J Pharmacol 2007;2:55-60
9. Mason RP, Mak IT, Trumbore MW, Mason PE. Antioxidant properties of calcium antagonists related to membrane biophysical interactions. Am J Cardiol 1999;84(4A):16L-22.
10. JNC 7 Express - The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of Blood Pressure.
11. Carré A. Pharmacologic importance of the combination atenolol/nifedipine in hypertensive patients. Drugs 1998;56 Suppl 2:23-30.
Statistics
307 Views | 626 Downloads
How to Cite
Panda, B. B., P. K. Sahu, and M. R. Pati. “SURVEY OF PRESCRIPTION PATTERN OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE AND DIABETIC HYPERTENSIVE PATIENTS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 8, no. 1, Jan. 2015, pp. 250-2, https://innovareacademics.in/journals/index.php/ajpcr/article/view/3686.
Section
Original Article(s)